Short Interest in Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Increases By 229.4%

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 41,500 shares, an increase of 229.4% from the February 29th total of 12,600 shares. Currently, 3.1% of the shares of the company are short sold. Based on an average trading volume of 199,300 shares, the short-interest ratio is currently 0.2 days.

Hedge Funds Weigh In On Creative Medical Technology

Large investors have recently bought and sold shares of the business. UBS Group AG bought a new stake in Creative Medical Technology in the first quarter valued at approximately $36,000. Citigroup Inc. bought a new position in Creative Medical Technology in the first quarter valued at $47,000. Geode Capital Management LLC grew its position in Creative Medical Technology by 261.8% in the first quarter. Geode Capital Management LLC now owns 124,224 shares of the company’s stock valued at $62,000 after purchasing an additional 89,886 shares in the last quarter. XTX Topco Ltd bought a new position in Creative Medical Technology in the first quarter valued at $68,000. Finally, State Street Corp bought a new position in Creative Medical Technology in the first quarter valued at $90,000. 1.42% of the stock is currently owned by institutional investors and hedge funds.

Creative Medical Technology Stock Performance

NASDAQ CELZ traded up $0.15 on Thursday, reaching $5.30. The company’s stock had a trading volume of 3,098 shares, compared to its average volume of 211,318. Creative Medical Technology has a 52 week low of $3.93 and a 52 week high of $13.30. The business has a 50-day moving average price of $4.65 and a 200 day moving average price of $4.67.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc, a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility.